NYSE: LLY produced Mounjaro are being swept up for off-label use
The most significant clinical data on retatrutide to date come from Phase 2 trials published in 2023, including a dose-ranging study published in The New England Journal of Medicine (Jastreboff et al., NEJM 2023)
Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, et al
Since early 2024, when the FDA cleared the first device that didnt need a prescription, the market for CGMs has exploded
Below we have a surcharge of 8.90 CHF Delivery within 24 - 48h L-carnitine is a sulfur-containing amino acid that the body produces from the amino acids L-lysine and L-methionine